wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33361626-A4ADEA37-8486-4043-906C-7ECF09268AC8
Q33361626-A4ADEA37-8486-4043-906C-7ECF09268AC8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33361626-A4ADEA37-8486-4043-906C-7ECF09268AC8
The ergogenic effect of recombinant human erythropoietin on VO2max depends on the severity of arterial hypoxemia.
P2860
Q33361626-A4ADEA37-8486-4043-906C-7ECF09268AC8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33361626-A4ADEA37-8486-4043-906C-7ECF09268AC8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2cb207d8a02eee944d2574e129cfd7730601e999
P2860
Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity.